WHO ICTRP trial
Phase II Clinical trial of personalized peptide vaccine for cancer patients…
JPRN-UMIN000006927 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000006927 |
|---|---|
| Public title | Phase II Clinical trial of personalized peptide vaccine for cancer patients - Effect of extended dose interval on the immun induction - |
| Scientific title | Phase II Clinical trial of personalized peptide vaccine for cancer patients - Effect of extended dose interval on the immun induction - - Personalized peptide vaccine trial for cancer patients - Effect of extended dose interval on the immun induction - |
| Primary sponsor | Kurume University Cancer Vaccine Center |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | malignant tumor |
| Interventions | (1st course: total 3 doses with 21-28 day interval) Select vaccine peptides (up to 4) from 31 candidate peptides , to which peptide-specific IgGs are detected before the 1st vaccination, and s.c. inject to the patient. If the patient hopes… |
| Registration date | Dec 21, 2011 |
| Target size | 60 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: